177 related articles for article (PubMed ID: 22002593)
1. Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.
Yang JQ; Kim PJ; Singh RR
J Clin Immunol; 2012 Feb; 32(1):106-13. PubMed ID: 22002593
[TBL] [Abstract][Full Text] [Related]
2. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
[TBL] [Abstract][Full Text] [Related]
3. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.
Yang JQ; Wen X; Kim PJ; Singh RR
J Immunol; 2011 Feb; 186(3):1512-20. PubMed ID: 21209282
[TBL] [Abstract][Full Text] [Related]
4. PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.
Parekh VV; Lalani S; Kim S; Halder R; Azuma M; Yagita H; Kumar V; Wu L; Kaer LV
J Immunol; 2009 Mar; 182(5):2816-26. PubMed ID: 19234176
[TBL] [Abstract][Full Text] [Related]
5. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
6. Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses.
Sedimbi SK; Hägglöf T; Garimella MG; Wang S; Duhlin A; Coelho A; Ingelshed K; Mondoc E; Malin SG; Holmdahl R; Lane DP; Leadbetter EA; Karlsson MCI
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9054-9063. PubMed ID: 32295878
[TBL] [Abstract][Full Text] [Related]
7. Rapid and reliable generation of invariant natural killer T-cell lines in vitro.
Chiba A; Cohen N; Brigl M; Brennan PJ; Besra GS; Brenner MB
Immunology; 2009 Nov; 128(3):324-33. PubMed ID: 20067532
[TBL] [Abstract][Full Text] [Related]
8. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset.
Sag D; Krause P; Hedrick CC; Kronenberg M; Wingender G
J Clin Invest; 2014 Sep; 124(9):3725-40. PubMed ID: 25061873
[TBL] [Abstract][Full Text] [Related]
9. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
[TBL] [Abstract][Full Text] [Related]
10. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
12. Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production.
Matsuda H; Takeda K; Koya T; Okamoto M; Shiraishi Y; Miyahara N; Dakhama A; Matsuda JL; Gapin L; Gelfand EW
J Immunol; 2010 Jul; 185(1):253-62. PubMed ID: 20525882
[TBL] [Abstract][Full Text] [Related]
13. A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.
Birkholz AM; Girardi E; Wingender G; Khurana A; Wang J; Zhao M; Zahner S; Illarionov PA; Wen X; Li M; Yuan W; Porcelli SA; Besra GS; Zajonc DM; Kronenberg M
J Immunol; 2015 Aug; 195(3):924-33. PubMed ID: 26078271
[TBL] [Abstract][Full Text] [Related]
14. Administration of α-Galactosylceramide Improves Adenine-Induced Renal Injury.
Aguiar CF; Naffah-de-Souza C; Castoldi A; Corrêa-Costa M; Braga TT; Naka ÉL; Amano MT; Abate DT; Hiyane MI; Cenedeze MA; Pacheco e Silva Filho A; Câmara NO
Mol Med; 2015 Jun; 21(1):553-62. PubMed ID: 26101952
[TBL] [Abstract][Full Text] [Related]
15. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
16. Invariant natural killer T cells contribute to the allergic response in cow's milk protein-sensitized mice.
Schouten B; van Esch BC; Lim SM; Hofman GA; Knippels LM; Willemsen LE; Vos AP; Garssen J
Int Arch Allergy Immunol; 2012; 159(1):51-9. PubMed ID: 22555211
[TBL] [Abstract][Full Text] [Related]
17. Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agents.
Bricard G; Venkataswamy MM; Yu KO; Im JS; Ndonye RM; Howell AR; Veerapen N; Illarionov PA; Besra GS; Li Q; Chang YT; Porcelli SA
PLoS One; 2010 Dec; 5(12):e14374. PubMed ID: 21179412
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic hyporesponsiveness of invariant natural killer T cells precedes the onset of lupus.
Yang JQ; Kim PJ; Halder RC; Singh RR
Clin Exp Immunol; 2013 Jul; 173(1):18-27. PubMed ID: 23607366
[TBL] [Abstract][Full Text] [Related]
19. Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity.
Umeshappa CS; Solé P; Yamanouchi J; Mohapatra S; Surewaard BGJ; Garnica J; Singha S; Mondal D; Cortés-Vicente E; D'Mello C; Mason A; Kubes P; Serra P; Yang Y; Santamaria P
Nat Commun; 2022 Jun; 13(1):3279. PubMed ID: 35672409
[TBL] [Abstract][Full Text] [Related]
20. Histamine receptor 2 modifies iNKT cell activity within the inflamed lung.
Ferstl R; Frei R; Barcik W; Schiavi E; Wanke K; Ziegler M; Rodriguez-Perez N; Groeger D; Konieczna P; Zeiter S; Nehrbass D; Lauener R; Akdis CA; O'Mahony L
Allergy; 2017 Dec; 72(12):1925-1935. PubMed ID: 28618071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
